All the news articles and press releases in one place.

Date / Time Source Ticker Company Sector Market Cap Announcement
09May24 14:35 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Posting of Annual Report and Notice of AGM
25Apr24 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Full year results and review of strategic options
08Apr24 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Notice of Full Year Results
19Mar24 14:47 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Exercise of Options and Total Voting Rights
31Jan24 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Clinical development update
22Jan24 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Appointment of Nominated Adviser and Sole Broker
04Jan24 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Year End Business Update
20Oct23 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Grant of Share Options
19Oct23 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Director/PDMR Shareholding
17Oct23 07:01 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - XF Pipeline Update Meeting
17Oct23 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Publication of new microbiological data for XF-73
10Oct23 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Director/PDMR Shareholding
04Oct23 12:34 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Director/PDMR Shareholding
27Sep23 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Notice of XF Pipeline Update Meeting
20Sep23 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Interim Results
23Aug23 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Notice of Interim Results
31Jul23 12:01 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Publication of new data for XF-73
25Jul23 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Appointment of new Chairman
19Jul23 12:55 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Board changes including appointment of new CEO
07Jul23 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Exercise of Options and Total Voting Rights
06Jul23 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Positive findings from recent SAB meeting
29Jun23 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Business Update
26May23 15:27 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Director/PDMR Shareholding
26May23 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Director Dealing
25May23 12:23 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Result of Annual General Meeting
25May23 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Dr Debra Barker Appointed Interim CEO
12May23 12:24 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Grant of Share Options
02May23 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Positive results from SPOR-COV® research
26Apr23 16:10 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Posting of Annual Report and Notice of AGM
26Apr23 10:05 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Exercise of Options and Total Voting Rights
13Apr23 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Audited results for year ended 31 December 2022
04Apr23 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Landmark data published on NTCD-M3
03Apr23 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Notice of Results and Investor Presentation
24Mar23 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Landmark XF-73 Phase 2 data published in journal
16Mar23 15:29 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Result of General Meeting and Total Voting Rights
15Mar23 16:02 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Result of Open Offer
06Mar23 10:50 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Exercise of Options and Total Voting Rights
06Mar23 10:31 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Holding(s) in Company
28Feb23 15:55 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Posting of Circular and Notice of General Meeting
27Feb23 16:30 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Director/PDMR Shareholding
24Feb23 13:32 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Agreement with Sebela Pharmaceutical for NTCD-M3
24Feb23 13:32 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Issue of Equity
26Jan23 10:10 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Exercise of Options and Total Voting Rights
25Jan23 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - US Center for Disease Control review paper
22Dec22 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Year End Trading Update
07Dec22 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - XF-73 Nasal final Phase 3 development plans
07Dec22 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - FDA/CDC highlight need for infection preventions
02Dec22 14:48 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Director Disclosure
23Nov22 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Appointment of Corporate Broker
21Nov22 14:19 DGAP-News DEST:LON Destiny Pharma Plc Health £15.7m EQS-News: Destiny Pharma PLC 'leads the world' in new approach to preventing hospital infections
18Nov22 13:16 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Director Shareholding Amendment
15Nov22 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - XF-73 advances to clinically enabling safety study
22Sep22 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Notice of R&D Update Meeting
08Sep22 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Interim results for six months ended 30 June 2022
07Sep22 07:03 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Presenting at HC Wainwright Investment Conference
07Sep22 07:01 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Positive update from EMA on NTCD-M3 Phase 3 plans
05Sep22 14:15 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Expiry of Share Options
22Aug22 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Notice of Interim Results
28Jul22 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Chair’s Investor Update
26Jul22 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Publication of new data on NTCD-M3
19Jul22 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Positive update from US FDA on XF-73 Phase 3
12Jul22 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Grant from the Cystic Fibrosis Foundation
07Jul22 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Publication of XF-73 drug synergy data
05Jul22 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - New XF-73 research programme
08Jun22 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Grant of share options
27May22 11:56 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Result of Annual General Meeting & Strategy Update
26May22 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Board Changes
12May22 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Landmark NTCD-M3 data to be presented at Anaerobe
03May22 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Destiny Pharma appoints Dr Yuri Martina as CMO
27Apr22 15:34 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Posting of Annual Report and Notice of AGM
26Apr22 15:30 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Director/PDMR Shareholding
12Apr22 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Audited results for year ended 31 December 2021
04Apr22 14:45 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Notice of Results
04Apr22 14:37 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Notification of Major Holdings
31Mar22 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - To present data at ECCMID Congress
28Mar22 11:30 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Result of General Meeting and Total Voting Rights
25Mar22 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Result of Open Offer
22Mar22 10:30 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Exercise of Options and Total Voting Rights
08Mar22 12:30 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Fundraising
08Feb22 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Positive feedback from EMA on XF-73 Nasal gel Ph 3
01Feb22 16:11 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Exercise of Options and Total Voting Rights
01Feb22 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Positive data in XF-73 Dermal study with NIAID
31Jan22 14:30 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Exercise of Options and Total Voting Rights
25Jan22 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Grant of share options
24Jan22 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Clinical and commercial opportunity of NTCD-M3
21Jan22 07:15 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Destiny Pharma Lancet Report
17Jan22 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Strategy/Company/Ops Update
21Dec21 16:35 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Exercise of Options and Total Voting Rights
17Dec21 09:46 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Grant of share options
15Nov21 14:26 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Directorate Change
04Nov21 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - SAB Member Prof. Gerding is Keynote at C.diff Conf
18Oct21 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Study gives strong support for potential of XF-73
27Sep21 15:18 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Director/PDMR Shareholding
27Sep21 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Expansion of clinical pipeline
09Sep21 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Interim results for six months ended 30 June 2021
23Aug21 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Notice of Interim Results
02Aug21 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Secondary endpoint analysis from Phase 2b trial
09Jul21 08:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - XF-73 Phase 2b data to be presented at ECCMID
06Jul21 07:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - NTCD-M3 RD Agreement with US Dept Veterans Affairs
02Jul21 08:00 RNS DEST:LON Destiny Pharma Plc Health £15.7m Destiny Pharma PLC - Scientific Advisor Gerding chairs C Diff symposium
Date / Time Source Company % Chg
09May24 14:35 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Posting of Annual Report and Notice of AGM
25Apr24 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Full year results and review of strategic options
08Apr24 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Notice of Full Year Results
19Mar24 14:47 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Exercise of Options and Total Voting Rights
31Jan24 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Clinical development update
22Jan24 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Appointment of Nominated Adviser and Sole Broker
04Jan24 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Year End Business Update
20Oct23 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Grant of Share Options
19Oct23 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Director/PDMR Shareholding
17Oct23 07:01 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - XF Pipeline Update Meeting
17Oct23 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Publication of new microbiological data for XF-73
10Oct23 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Director/PDMR Shareholding
04Oct23 12:34 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Director/PDMR Shareholding
27Sep23 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Notice of XF Pipeline Update Meeting
20Sep23 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Interim Results
23Aug23 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Notice of Interim Results
31Jul23 12:01 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Publication of new data for XF-73
25Jul23 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Appointment of new Chairman
19Jul23 12:55 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Board changes including appointment of new CEO
07Jul23 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Exercise of Options and Total Voting Rights
06Jul23 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Positive findings from recent SAB meeting
29Jun23 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Business Update
26May23 15:27 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Director/PDMR Shareholding
26May23 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Director Dealing
25May23 12:23 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Result of Annual General Meeting
25May23 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Dr Debra Barker Appointed Interim CEO
12May23 12:24 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Grant of Share Options
02May23 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Positive results from SPOR-COV® research
26Apr23 16:10 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Posting of Annual Report and Notice of AGM
26Apr23 10:05 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Exercise of Options and Total Voting Rights
13Apr23 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Audited results for year ended 31 December 2022
04Apr23 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Landmark data published on NTCD-M3
03Apr23 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Notice of Results and Investor Presentation
24Mar23 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Landmark XF-73 Phase 2 data published in journal
16Mar23 15:29 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Result of General Meeting and Total Voting Rights
15Mar23 16:02 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Result of Open Offer
06Mar23 10:50 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Exercise of Options and Total Voting Rights
06Mar23 10:31 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Holding(s) in Company
28Feb23 15:55 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Posting of Circular and Notice of General Meeting
27Feb23 16:30 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Director/PDMR Shareholding
24Feb23 13:32 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Agreement with Sebela Pharmaceutical for NTCD-M3
24Feb23 13:32 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Issue of Equity
26Jan23 10:10 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Exercise of Options and Total Voting Rights
25Jan23 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - US Center for Disease Control review paper
22Dec22 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Year End Trading Update
07Dec22 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - XF-73 Nasal final Phase 3 development plans
07Dec22 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - FDA/CDC highlight need for infection preventions
02Dec22 14:48 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Director Disclosure
23Nov22 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Appointment of Corporate Broker
21Nov22 14:19 DGAP-News Destiny Pharma Plc 4.76%
EQS-News: Destiny Pharma PLC 'leads the world' in new approach to preventing hospital infections
18Nov22 13:16 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Director Shareholding Amendment
15Nov22 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - XF-73 advances to clinically enabling safety study
22Sep22 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Notice of R&D Update Meeting
08Sep22 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Interim results for six months ended 30 June 2022
07Sep22 07:03 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Presenting at HC Wainwright Investment Conference
07Sep22 07:01 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Positive update from EMA on NTCD-M3 Phase 3 plans
05Sep22 14:15 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Expiry of Share Options
22Aug22 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Notice of Interim Results
28Jul22 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Chair’s Investor Update
26Jul22 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Publication of new data on NTCD-M3
19Jul22 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Positive update from US FDA on XF-73 Phase 3
12Jul22 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Grant from the Cystic Fibrosis Foundation
07Jul22 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Publication of XF-73 drug synergy data
05Jul22 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - New XF-73 research programme
08Jun22 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Grant of share options
27May22 11:56 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Result of Annual General Meeting & Strategy Update
26May22 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Board Changes
12May22 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Landmark NTCD-M3 data to be presented at Anaerobe
03May22 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Destiny Pharma appoints Dr Yuri Martina as CMO
27Apr22 15:34 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Posting of Annual Report and Notice of AGM
26Apr22 15:30 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Director/PDMR Shareholding
12Apr22 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Audited results for year ended 31 December 2021
04Apr22 14:45 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Notice of Results
04Apr22 14:37 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Notification of Major Holdings
31Mar22 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - To present data at ECCMID Congress
28Mar22 11:30 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Result of General Meeting and Total Voting Rights
25Mar22 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Result of Open Offer
22Mar22 10:30 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Exercise of Options and Total Voting Rights
08Mar22 12:30 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Fundraising
08Feb22 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Positive feedback from EMA on XF-73 Nasal gel Ph 3
01Feb22 16:11 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Exercise of Options and Total Voting Rights
01Feb22 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Positive data in XF-73 Dermal study with NIAID
31Jan22 14:30 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Exercise of Options and Total Voting Rights
25Jan22 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Grant of share options
24Jan22 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Clinical and commercial opportunity of NTCD-M3
21Jan22 07:15 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Destiny Pharma Lancet Report
17Jan22 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Strategy/Company/Ops Update
21Dec21 16:35 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Exercise of Options and Total Voting Rights
17Dec21 09:46 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Grant of share options
15Nov21 14:26 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Directorate Change
04Nov21 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - SAB Member Prof. Gerding is Keynote at C.diff Conf
18Oct21 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Study gives strong support for potential of XF-73
27Sep21 15:18 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Director/PDMR Shareholding
27Sep21 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Expansion of clinical pipeline
09Sep21 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Interim results for six months ended 30 June 2021
23Aug21 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Notice of Interim Results
02Aug21 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Secondary endpoint analysis from Phase 2b trial
09Jul21 08:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - XF-73 Phase 2b data to be presented at ECCMID
06Jul21 07:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - NTCD-M3 RD Agreement with US Dept Veterans Affairs
02Jul21 08:00 RNS Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Scientific Advisor Gerding chairs C Diff symposium
Date / Time Company % Chg
09May24 14:35 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Posting of Annual Report and Notice of AGM
25Apr24 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Full year results and review of strategic options
08Apr24 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Notice of Full Year Results
19Mar24 14:47 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Exercise of Options and Total Voting Rights
31Jan24 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Clinical development update
22Jan24 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Appointment of Nominated Adviser and Sole Broker
04Jan24 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Year End Business Update
20Oct23 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Grant of Share Options
19Oct23 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Director/PDMR Shareholding
17Oct23 07:01 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - XF Pipeline Update Meeting
17Oct23 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Publication of new microbiological data for XF-73
10Oct23 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Director/PDMR Shareholding
04Oct23 12:34 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Director/PDMR Shareholding
27Sep23 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Notice of XF Pipeline Update Meeting
20Sep23 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Interim Results
23Aug23 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Notice of Interim Results
31Jul23 12:01 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Publication of new data for XF-73
25Jul23 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Appointment of new Chairman
19Jul23 12:55 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Board changes including appointment of new CEO
07Jul23 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Exercise of Options and Total Voting Rights
06Jul23 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Positive findings from recent SAB meeting
29Jun23 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Business Update
26May23 15:27 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Director/PDMR Shareholding
26May23 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Director Dealing
25May23 12:23 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Result of Annual General Meeting
25May23 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Dr Debra Barker Appointed Interim CEO
12May23 12:24 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Grant of Share Options
02May23 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Positive results from SPOR-COV® research
26Apr23 16:10 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Posting of Annual Report and Notice of AGM
26Apr23 10:05 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Exercise of Options and Total Voting Rights
13Apr23 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Audited results for year ended 31 December 2022
04Apr23 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Landmark data published on NTCD-M3
03Apr23 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Notice of Results and Investor Presentation
24Mar23 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Landmark XF-73 Phase 2 data published in journal
16Mar23 15:29 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Result of General Meeting and Total Voting Rights
15Mar23 16:02 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Result of Open Offer
06Mar23 10:50 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Exercise of Options and Total Voting Rights
06Mar23 10:31 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Holding(s) in Company
28Feb23 15:55 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Posting of Circular and Notice of General Meeting
27Feb23 16:30 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Director/PDMR Shareholding
24Feb23 13:32 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Agreement with Sebela Pharmaceutical for NTCD-M3
24Feb23 13:32 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Issue of Equity
26Jan23 10:10 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Exercise of Options and Total Voting Rights
25Jan23 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - US Center for Disease Control review paper
22Dec22 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Year End Trading Update
07Dec22 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - XF-73 Nasal final Phase 3 development plans
07Dec22 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - FDA/CDC highlight need for infection preventions
02Dec22 14:48 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Director Disclosure
23Nov22 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Appointment of Corporate Broker
21Nov22 14:19 Destiny Pharma Plc 4.76%
EQS-News: Destiny Pharma PLC 'leads the world' in new approach to preventing hospital infections
18Nov22 13:16 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Director Shareholding Amendment
15Nov22 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - XF-73 advances to clinically enabling safety study
22Sep22 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Notice of R&D Update Meeting
08Sep22 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Interim results for six months ended 30 June 2022
07Sep22 07:03 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Presenting at HC Wainwright Investment Conference
07Sep22 07:01 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Positive update from EMA on NTCD-M3 Phase 3 plans
05Sep22 14:15 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Expiry of Share Options
22Aug22 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Notice of Interim Results
28Jul22 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Chair’s Investor Update
26Jul22 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Publication of new data on NTCD-M3
19Jul22 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Positive update from US FDA on XF-73 Phase 3
12Jul22 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Grant from the Cystic Fibrosis Foundation
07Jul22 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Publication of XF-73 drug synergy data
05Jul22 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - New XF-73 research programme
08Jun22 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Grant of share options
27May22 11:56 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Result of Annual General Meeting & Strategy Update
26May22 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Board Changes
12May22 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Landmark NTCD-M3 data to be presented at Anaerobe
03May22 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Destiny Pharma appoints Dr Yuri Martina as CMO
27Apr22 15:34 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Posting of Annual Report and Notice of AGM
26Apr22 15:30 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Director/PDMR Shareholding
12Apr22 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Audited results for year ended 31 December 2021
04Apr22 14:45 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Notice of Results
04Apr22 14:37 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Notification of Major Holdings
31Mar22 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - To present data at ECCMID Congress
28Mar22 11:30 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Result of General Meeting and Total Voting Rights
25Mar22 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Result of Open Offer
22Mar22 10:30 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Exercise of Options and Total Voting Rights
08Mar22 12:30 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Fundraising
08Feb22 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Positive feedback from EMA on XF-73 Nasal gel Ph 3
01Feb22 16:11 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Exercise of Options and Total Voting Rights
01Feb22 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Positive data in XF-73 Dermal study with NIAID
31Jan22 14:30 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Exercise of Options and Total Voting Rights
25Jan22 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Grant of share options
24Jan22 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Clinical and commercial opportunity of NTCD-M3
21Jan22 07:15 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Destiny Pharma Lancet Report
17Jan22 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Strategy/Company/Ops Update
21Dec21 16:35 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Exercise of Options and Total Voting Rights
17Dec21 09:46 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Grant of share options
15Nov21 14:26 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Directorate Change
04Nov21 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - SAB Member Prof. Gerding is Keynote at C.diff Conf
18Oct21 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Study gives strong support for potential of XF-73
27Sep21 15:18 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Director/PDMR Shareholding
27Sep21 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Expansion of clinical pipeline
09Sep21 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Interim results for six months ended 30 June 2021
23Aug21 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Notice of Interim Results
02Aug21 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Secondary endpoint analysis from Phase 2b trial
09Jul21 08:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - XF-73 Phase 2b data to be presented at ECCMID
06Jul21 07:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - NTCD-M3 RD Agreement with US Dept Veterans Affairs
02Jul21 08:00 Destiny Pharma Plc 4.76%
Destiny Pharma PLC - Scientific Advisor Gerding chairs C Diff symposium